InsiderClue
← All stocks

aTYR PHARMA INC

ATYR Net buying
CIK 0001339970 #4704 in the set updated 19 Sep 2026
Bought (120 mo)
$6.72M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.21M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$3.21M
28 of 28 sales
Net
+$3.51M
+$3.51M against sales at will

By person

13 insiders · 80 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SCHIMMEL PAUL
Director
$5.69M (21)
$30.74K (1)
+$5.66M
1,217,176
1.24%
$604.08K
—
EcoR1 Capital Fund Qualified, L.P. entity
10% owner
$143.33K (2)
$3.06M (7)
−$2.91M
0
0.0000%
$0.00
−100.0%
MENDLEIN JOHN
Director
$362.94K (7)
—
+$362.94K
615,382
0.6274%
$305.41K
+135.8%
Shukla Sanjay
President and CEO
$286.25K (12)
$12.62K (3)
+$273.63K
153,553
0.1565%
$76.21K
+61,321%
Coughlin Timothy
Director
$87.50K (1)
—
+$87.50K
56,000
0.0571%
$27.79K
—
Broadfoot Jill Marie
Chief Financial Officer
$101.65K (6)
$17.14K (6)
+$84.51K
37,296
0.0380%
$18.51K
—
CLARKE JOHN K
Director
—
$72.06K (5)
−$72.06K
127,880
0.1304%
$63.47K
−8.3%
Amanullah Ashraf
See Remarks
$24.75K (1)
$4.77K (1)
+$19.98K
26,264
0.0268%
$13.03K
+162.7%
Gross Jane A
Director
$15.00K (1)
—
+$15.00K
9,750
0.0099%
$4.84K
—
Blake John T
Senior Vice President, Finance
—
$4.77K (1)
−$4.77K
1,932
0.0020%
$958.85
—
DENYES NANCY
General Counsel
$9.28K (1)
$7.75K (4)
+$1.53K
33,124
0.0338%
$16.44K
+201.9%
Lucas Svetlana
Director
—
—
—
6,000
0.0061%
$2.98K
—
Zaknoen Sara
Director
—
—
—
6,000
0.0061%
$2.98K
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 183
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 2,517,571
Sales filed before the plan box existed 22
History held since 15 Sep 2016